|
|||||
|
|
Assessing the validity,responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment |
|
| Authors: | A.B. Kimball G.B.E. Jemec M. Yang A. Kageleiry J.E. Signorovitch M.M. Okun Y. Gu K. Wang P. Mulani M. Sundaram |
| Affiliation: | 1. Department of Dermatology, Harvard Medical School, , Boston, MA, U.S.A;2. Department of Dermatology, Roskilde Hospital, Health Sciences Faculty, University of Copenhagen, , Copenhagen, Denmark;3. Analysis Group, Inc., , Boston, MA, U.S.A;4. Global Pharmaceutical Research and Development, AbbVie Inc., , North Chicago, IL, U.S.A;5. Lilly Suzhou Pharmaceutical Co. Ltd, Shanghai Branch, , Shanghai, China |
| Abstract: | |
| Keywords: | |